Bonnie Wu
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Virus-based gene therapy research, Advanced Biosensing Techniques and Applications
Most-Cited Works
- → High-throughput DNA methylation profiling using universal bead arrays(2006)672 cited
- → Human embryonic stem cells have a unique epigenetic signature(2006)271 cited
- → Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics(2016)69 cited
- → Characterization of the Proline-Rich Region of Murine Leukemia Virus Envelope Protein(1998)62 cited
- → 2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( Part 3 –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)(2021)60 cited
- → 2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 3 – Lba, Biomarkers and Immunogenicity)(2016)58 cited
- → Identification of Regions in the Moloney Murine Leukemia Virus SU Protein That Tolerate the Insertion of an Integrin-Binding Peptide(2000)51 cited
- → Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays(2021)49 cited
- → Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy(2023)38 cited
- → 2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness ( Part 3 – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)(2022)33 cited